Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.4 indicates a new build of the ClinicalTrials.gov interface. This is a routine release update and does not modify the listed study details or eligibility criteria.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe ClinicalTrials.gov page footer was updated to a new software/site revision version (from v3.5.2 to v3.5.3). This reflects a site/version update rather than any change to the study record information.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check76 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No substantive study details appear to have changed.SummaryDifference0.1%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.